1
|
Foguet-Boreu Q, Vilamala-Orra M, Vaqué-Crusellas C, Roura-Poch P, Assens Tauste M, Bori Vila J, Santos-López JM, Del Río Sáez R. Metabolic impact of a nutrition education program for the promotion of fruit and vegetable consumption with people with severe mental disorders (DIETMENT). BMC Res Notes 2022; 15:122. [PMID: 35351204 PMCID: PMC8962513 DOI: 10.1186/s13104-022-06005-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Accepted: 03/15/2022] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVES The aim of this study is to determine the metabolic impact of a nutrition education program on metabolic parameters and the presence of metabolic syndrome (MetS). RESULTS Seventy-four patients were included (mean age, 48.7 years [Standard deviation, SD: 10.8], 55.4% men). The diagnoses of SMD were 37.8% schizophrenia and related disorders; 29.7% bipolar disorder; 25.7% depressive disorder; 4.1% personality disorders; and 2.7% obsessive compulsive disorders. Thirty-seven individuals were distributed in both the intervention group (IG) and the control group (CG). In the IG the presence of MetS was 56.3% and in the CG 46.7%, with no statistically significant difference (p = 0.309). At the end of the study, glomerular filtrate decreased in the IG, body mass index and abdominal perimeter increased in both groups, and there were no changes in metabolic parameters between the groups. Between the baseline and the end of the study, there was no increase in the number of patients diagnosed with MetS (14 at both points); and in the CG the increase was from 8 to 12 (p = 0.005). An intervention based on fruit and vegetable intake could prevent progression to MetS in individuals with SMD, decreasing the likelihood of cardiovascular disease. Trial registration The trial was retrospectively registered on International Standard Randomised Controlled Trial Number (ISRCTN) Register on 11 March 2022 (ISRCTN12024347).
Collapse
Affiliation(s)
- Quintí Foguet-Boreu
- Multidisciplinary Research Group in Mental Health, Department of Psychiatry, Vic University Hospital, 08500, Vic, Spain. .,Department of Psychiatry, Vic University Hospital, 08500, Vic, Spain. .,Faculty of Medicine, University of Vic - Central University of Catalonia, Vic, Barcelona, Spain.
| | - Mireia Vilamala-Orra
- Research Group on Methodology, Methods, Models and Outcomes of Health and Social Sciences (M3O), Faculty of Health Sciences and Welfare, University of Vic - Central University of Catalonia, 08500, Vic, Spain.,Osonament - Osona Psychopedagogical Medical Center Foundation, 08500, Vic, Spain
| | - Cristina Vaqué-Crusellas
- Research Group on Methodology, Methods, Models and Outcomes of Health and Social Sciences (M3O), Faculty of Health Sciences and Welfare, University of Vic - Central University of Catalonia, 08500, Vic, Spain
| | - Pere Roura-Poch
- Department of Clinical Epidemiology, Vic University Hospital, 08500, Vic, Spain
| | | | - Judit Bori Vila
- Department of Psychiatry, Vic University Hospital, 08500, Vic, Spain
| | - Jose Manuel Santos-López
- Department of Psychiatry, Vic University Hospital, 08500, Vic, Spain.,Mental Health and Social Innovation Research Group (SaMIS), University of Vic-Central University of Catalonia, 08500, Vic, Spain
| | - Ruben Del Río Sáez
- Osonament - Osona Psychopedagogical Medical Center Foundation, 08500, Vic, Spain.,Mental Health and Social Innovation Research Group (SaMIS), University of Vic-Central University of Catalonia, 08500, Vic, Spain
| |
Collapse
|
2
|
Schizophrenia Outside the Brain. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2022; 1400:53-63. [DOI: 10.1007/978-3-030-97182-3_4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
3
|
Govindan R, Rangaswamy T, John S, Kandasamy S. Methodology for Development of a Community Level Intervention Module for Physical Illness in Persons with Mental Illness (CLIPMI). Indian J Psychol Med 2020; 42:S94-S98. [PMID: 33487810 PMCID: PMC7802035 DOI: 10.1177/0253717620973381] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND AND OBJECTIVES Medical illnesses seen in persons with psychiatric disorders are important but often ignored causes of increased morbidity and mortality. Hence, a community level intervention program addressing the issue is proposed. MATERIALS AND METHODS Patients with severe mental illnesses will be identified by a door-to-door survey and assessed for comorbid physical illnesses like anemia, hypertension, diabetes, and so on. They will then be randomized into two groups. The treatment as usual (TAU) group will not receive intervention from the trained community level workers, while the Intervention group will receive it. RESULTS The two groups will be compared for the prevalence and severity of comorbid physical illnesses. The expected outcome is compared to the TAU group, the intervention group will have a greater reduction in the morbidity due to physical illnesses and improved mental health. CONCLUSION If successful, the module can be incorporated into the community level mental health delivery system of the District Mental Health Program (DMHP).
Collapse
Affiliation(s)
| | | | - Sujit John
- Schizophrenia Research Foundation, Chennai, Tamil Nadu, India
| | | |
Collapse
|
4
|
Roberts T, Gureje O, Thara R, Hutchinson G, Cohen A, Weiss HA, John S, Lee Pow J, Donald C, Olley B, Miguel Esponda G, Murray RM, Morgan C. INTREPID II: protocol for a multistudy programme of research on untreated psychosis in India, Nigeria and Trinidad. BMJ Open 2020; 10:e039004. [PMID: 32565481 PMCID: PMC7311008 DOI: 10.1136/bmjopen-2020-039004] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
INTRODUCTION There are few robust and directly comparable studies of the epidemiology of psychotic disorders in the Global South. INTREPID II is designed to investigate variations in untreated psychotic disorders in the Global South in (1) incidence and presentation (2) 2-year course and outcome, (3) help-seeking and impact, and (4) physical health. METHODS INTREPID II is a programme of research incorporating incidence, case-control and cohort studies of psychoses in contiguous urban and rural areas in India, Nigeria and Trinidad. In each country, the target samples are 240 untreated cases with a psychotic disorder, 240 age-matched, sex-matched and neighbourhood-matched controls, and 240 relatives or caregivers. Participants will be followed, in the first instance, for 2 years. In each setting, we have developed and are employing comprehensive case-finding methods to ensure cohorts are representative of the target populations. Using methods developed during pilot work, extensive data are being collected at baseline and 2-year follow-up across several domains: clinical, social, help-seeking and impact, and biological. ETHICS AND DISSEMINATION Informed consent is sought, and participants are free to withdraw from the study at any time. Participants are referred to mental health services if not already in contact with these and emergency treatment arranged where necessary. All data collected are confidential, except when a participant presents a serious risk to either themselves or others. This programme has been approved by ethical review boards at all participating centres. Findings will be disseminated through international conferences, publications in international journals, and through local events for key stakeholders.
Collapse
Affiliation(s)
- Tessa Roberts
- Health Service & Population Research department, Institute of Psychiatry Psychology and Neuroscience, London, UK
- ESRC Centre for Society and Mental Health, King's College London, London, UK
| | - Oye Gureje
- WHO Collaborating Centre for Research and Training in Mental Health, Neuroscience and Substance Abuse, Department of Psychiatry, University of Ibadan, Ibadan, Oyo, Nigeria
| | | | - Gerard Hutchinson
- Department of Psychiatry, The University of the West Indies at Saint Augustine Faculty of Medical Sciences, Saint Augustine, Tunapuna-Piarco, Trinidad and Tobago
| | - Alex Cohen
- Department of Epidemiology, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA
| | - Helen Anne Weiss
- Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
- London School of Hygiene and Tropical Medicine, London, UK
| | - Sujit John
- Schizophrenia Research Foundation, Chennai, India
| | - Joni Lee Pow
- Department of Psychiatry, The University of the West Indies at Saint Augustine Faculty of Medical Sciences, Saint Augustine, Tunapuna-Piarco, Trinidad and Tobago
| | - Casswina Donald
- Department of Psychiatry, The University of the West Indies at Saint Augustine Faculty of Medical Sciences, Saint Augustine, Tunapuna-Piarco, Trinidad and Tobago
| | - Bola Olley
- Department of Psychiatry, University of Ibadan College of Medicine, Ibadan, Oyo, Nigeria
| | - Georgina Miguel Esponda
- Health Service & Population Research department, Institute of Psychiatry Psychology and Neuroscience, London, UK
- ESRC Centre for Society and Mental Health, King's College London, London, UK
| | - Robin M Murray
- Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, London, UK
| | - Craig Morgan
- Health Service & Population Research department, Institute of Psychiatry Psychology and Neuroscience, London, UK
- ESRC Centre for Society and Mental Health, King's College London, London, UK
| |
Collapse
|
5
|
Anjum S, Bathla M. A comparative study of prevalence and predictors of metabolic syndrome in various psychiatric disorders in state of Haryana: More than 30 years Vs. less than 30 years. Diabetes Metab Syndr 2019; 13:510-516. [PMID: 30641756 DOI: 10.1016/j.dsx.2018.11.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2018] [Accepted: 11/02/2018] [Indexed: 12/30/2022]
Abstract
BACKGROUND Exponential growth of metabolic syndrome in psychiatric disorders is becoming alarming situation to handle with. It is associated with reduced life span of 10-30 years in psychiatric patients attributed to metabolic syndrome, thus needs to be screened and addressed in all psychiatric patients. OBJECTIVE the objective of this study was to know the prevalence and its risk factors in various psychiatric disorder and comparing them in older vs younger patients. METHODOLOGY A cross sectional indoor based study was conducted after taking ethical committee approval in 140 patients (substance use disorder, schizophrenia, bipolar and depressive disorders). All the metabolic parameters as per International diabetes federation criteria for metabolic syndrome were assessed involving waist circumference, weight, height, Systolic/diastolic blood pressure, fasting blood sugar, high density lipoprotein and triglycerides. STATISTICS Chi square and t-test were used. RESULTS It was seen that prevalence of metabolic syndrome (MS); 21.4% in psychiatric illness, up to 40% in major depressive disorders, followed by 33% in substance use disorder and 26.7% in psychotic disorders. Prevalence of MS was higher in older patients >30 years group (26% Vs. 16.4% in <30 years group). It was observed that substance use and depressive disorder and high BP in older male patients are all the significant risk factors for metabolic syndrome. CONCLUSION More than 1/5th psychiatric patients are affected by metabolic syndrome. Thus, all male psychiatric patients with high BP must be evaluated for metabolic syndrome.
Collapse
Affiliation(s)
- Shazia Anjum
- MM Institute of Medical Sciences and Research, Mullana, Ambala, India
| | - Manish Bathla
- MM Institute of Medical Sciences and Research, Mullana, Ambala, India.
| |
Collapse
|
6
|
Sun L, Getz M, Daboul S, Jay M, Sherman S, Rogers E, Aujero N, Rosedale M, Goetz RR, Weissman J, Malaspina D, Ahmad S. Independence of diabetes and obesity in adults with serious mental illness: Findings from a large urban public hospital. J Psychiatr Res 2018; 99:159-166. [PMID: 29482065 PMCID: PMC9714959 DOI: 10.1016/j.jpsychires.2018.01.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Revised: 12/26/2017] [Accepted: 01/11/2018] [Indexed: 12/12/2022]
Abstract
OBJECTIVE There is limited research on metabolic abnormalities in psychotropic-naïve patients with serious mental illness (SMI). Our study examined metabolic conditions in a large, ethnically diverse sample of psychotropic-naïve and non-naïve adults with SMI at an urban public hospital. METHODS In this cross-sectional study of 923 subjects, the prevalences of hyperglycemia meeting criteria for type 2 diabetes mellitus (T2DM) based on fasting plasma glucose and obesity defined by BMI and abdominal girth were compared across duration of psychotropic medication exposure. Multiple logistic regression models used hyperglycemia and obesity as dependent variables and age, sex, race/ethnicity, and years on psychotropics as independent variables. RESULTS Psychotropic-naïve patients, including both schizophrenia and non-psychotic subgroups, showed an elevated prevalence of hyperglycemia meeting criteria for T2DM and a decreased prevalence of obesity compared to the general population. Obesity rates significantly increased for those on psychotropic medications more than 5 years, particularly for patients without psychosis (BMI: aOR = 5.23 CI = 1.44-19.07; abdominal girth: aOR = 6.40 CI = 1.98-20.69). Women had a significantly higher obesity rate than men (BMI: aOR = 1.63 CI = 1.17-2.28; abdominal girth: aOR = 3.86 CI = 2.75-5.44). Asians had twice the prevalence of hyperglycemia as whites (aOR = 2.29 CI = 1.43-3.67), despite having significantly less obesity (BMI: aOR = .39 CI = .20-.76; abdominal girth: aOR = .34 CI = .20-.60). Hispanics had a higher rate of obesity by BMI than whites (aOR = 1.91 CI = 1.22-2.99). CONCLUSIONS This study showed disparities between obesity and T2DM in psychotropic-naïve patients with SMI, suggesting separate risk pathways for these two metabolic conditions.
Collapse
Affiliation(s)
- Langston Sun
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States
| | - Mara Getz
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States
| | - Sulaima Daboul
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States
| | - Melanie Jay
- New York University, Division of General Internal Medicine and Clinical Innovation, New York, NY, United States; Veterans Affairs New York Harbor Healthcare System, New York, NY, United States
| | - Scott Sherman
- New York University, Department of Population Health, New York, NY, United States; Veterans Affairs New York Harbor Healthcare System, New York, NY, United States
| | - Erin Rogers
- New York University, Department of Population Health, New York, NY, United States
| | - Nicole Aujero
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States
| | - Mary Rosedale
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States; New York University, College of Nursing (deceased), New York, NY, United States
| | - Raymond R Goetz
- New York State Psychiatric Institute and Columbia University Department of Psychiatry, New York, NY, United States
| | - Judith Weissman
- Icahn School of Medicine at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, United States; Veterans Affairs New York Harbor Healthcare System, New York, NY, United States
| | - Dolores Malaspina
- Icahn School of Medicine at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, United States.
| | - Samoon Ahmad
- New York University School of Medicine, Department of Psychiatry, New York, NY, United States
| |
Collapse
|